Hemophilia Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast
Hemophilia is a genetic disorder where the body fails to coagulate blood when blood vessel is ruptured. Between its variants, hemophilia A is more common than hemophilia B. A very rare form of hemophilia namely acquired hemophilia results from abnormalities in immune system of an individual. Acquired hemophilia is not a genetic disorder. Common symptoms of hemophilia are internal and external bleeding episodes.
View full press release